Who owns the LIPOSOMAL GLYCINE+ trademark?

The LIPOSOMAL GLYCINE+ trademark is owned by Spartacus Brands LLC.

What class is the LIPOSOMAL GLYCINE+ trademark registered in?

The LIPOSOMAL GLYCINE+ trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LIPOSOMAL GLYCINE+?

The USPTO serial number for LIPOSOMAL GLYCINE+ is 99361679.

What is the registration number for LIPOSOMAL GLYCINE+?

LIPOSOMAL GLYCINE+ is registered under USPTO registration number 0.

LIP

USPTO Trademark Record

ABANDONED

LIPOSOMAL GLYCINE+

SN 99361679·Reg 0·Filed Aug 27, 2025

Owner Spartacus Brands LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LIPOSOMAL GLYCINE+ (Serial No. 99361679), Registration No. 0, is a abandoned US trademark filed on Aug 27, 2025 by Spartacus Brands LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

LIPOSOMAL GLYCINE+ (Reg. #0) is an abandoned US trademark that was filed in 2025 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Aug 27, 2025

SERIAL

99361679

REG#

Owner

Applicant

Spartacus Brands LLC

Entity

LLC

State

Address

1606 Headway Circle, Suite 9769, Austin, TX, 78754

Country

Attorney

NameOmid E. Khalifeh

Law firm

Omid E. Khalifeh Omni Legal Group

Address

10880 Wilshire Blvd., Suite 1860, Los Angeles, CA 90024, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateAug 27, 2025

Serial Number99361679

Registration No.0

Status DateJun 22, 2026

Mark TypeStandard characters

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Dec 11, 2024

First use in commerce: Dec 11, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jun 22, 2026

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jun 22, 2026

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ATTORNEY REVIEW COMPLETED

Jun 20, 2026

ATTORNEY REVIEW COMPLETED

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Feb 27, 2026

JURISDICTION RESTORED TO EXAMINING ATTORNEY

LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN

Feb 27, 2026

LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN

NON-FINAL ACTION WRITTEN

Feb 27, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 27, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 27, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 20, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 20, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 20, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

LETTER OF PROTEST EVIDENCE FORWARDED

Feb 19, 2026

LETTER OF PROTEST EVIDENCE FORWARDED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 17, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Feb 04, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 04, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 04, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 04, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 04, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 04, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Jan 20, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 16, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 27, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 27, 2025

APPLICATION FILING RECEIPT MAILED

LIPOSOMAL GLYCINE+

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Spartacus Brands LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Omid E. Khalifeh

Resources

Company